Biotech · Private company
Vima Therapeutics
Track this companyFree. Adds Vima Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- VIM0423Phase 2 · DystoniaClinicalTrials.gov · fetched Nov 12, 2026
- VIM0423Phase 2 · PARKINSON DISEASE (Disorder)ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic TherapyPHASE2 · RECRUITING · started Sep 15, 2026ClinicalTrials.gov NCT07804615 · fetched Nov 12, 2026
- A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated DystoniaPHASE2 · RECRUITING · started Feb 5, 2026ClinicalTrials.gov NCT07304089 · fetched Nov 12, 2026
- An Observational Study of Individuals With Isolated DystoniaACTIVE_NOT_RECRUITING · started Jun 17, 2025ClinicalTrials.gov NCT07111663 · fetched Nov 12, 2026